Enzyme induction by drugs and toxins

Area of Science:

• Pharmacology
• Biochemistry
• Drug Metabolism

Background:

• Enzyme induction by drugs primarily involves enzymes critical for drug metabolism, including cytochromes P-450, UDP-glucuronosyltransferases, glutathione S-transferases, gamma-glutamyltransferases, and epoxide hydrolases.
• While numerous enzyme forms exist, not all are inducible; inducible cytochromes P-450 in humans belong to families IA, IIA, IIC, IIE, and IIIA.
• Enzyme induction predominantly occurs in the liver but can also be observed in other organs like the lung, placenta, and lymphocytes.

Purpose of the Study:

• To highlight the significance of enzyme induction in drug metabolism and its clinical implications.
• To emphasize the need for early identification of enzyme-inducing properties during drug development.
• To discuss the consequences of enzyme induction on drug pharmacokinetics.

Main Methods:

• Review of existing literature on drug-induced enzyme induction.
• Identification of key enzyme families involved in drug metabolism and their inducibility.
• Analysis of the impact of enzyme induction on drug pharmacokinetics.

Main Results:

• A limited number of drugs and environmental chemicals have been identified as enzyme inducers.
• Enzyme induction can alter the pharmacokinetics of the drug itself or co-administered drugs.
• Advancements in methods for identifying enzyme inducers have been made.

Conclusions:

• Early assessment of enzyme-inducing properties is essential for new drug development.
• Information on enzyme induction should be readily available to healthcare professionals.
• Understanding enzyme induction is critical for safe and effective drug therapy.